Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
1,091
result(s) for
"United States. Congress. Conference Committees."
Sort by:
Crossing the Line
According to public acknowledgement by former Chairman Dempsey of the Joint Chiefs of Staff, the U.S. had not declared exactly what kinds of cyber-attacks and what level of damage hits the threshold of an \"act of war. First came confirmation that existing international law principles do apply in cyber-space; it is not a \"law-free\" zone. This recognition is really no different than that which occurred with other technological advances in the past, such as the airplane's impact on warfare, or the opening of new physical domains, including outer space with restrictions and, in contrast, peaceful use of Antarctica. [...]this added economic weapon helps extend our layered cyber national defenses to attacks that do not necessarily trigger a DOD led response. [...]the President approved, amending Executive Order 13964 to authorize sanctions on those who: \"tamper with, alter, or cause a misappropriation of information with the purpose or effect of interfering with or undermining election processes or institutions. This article is based upon a presentation by Mr. O'Neill at the ABA Spring meeting of the International Section in Washington D.C. on April 26, 2017.
Journal Article
New Directions in Congressional Politics
As the U.S. Congress has steadily evolved since the Founding of our nation, so too has our understanding of the institution. The second edition of New Directions in Congressional Politics offers an accessible overview of the current developments in our understanding of America's legislative branch. Jamie L. Carson and Michael S. Lynch help students bridge the gap between roles, rules, and outcomes by focusing on a variety of thematic issues: the importance of electoral considerations, legislators' strategic behavior to accomplish objectives, the unique challenges of Congress as a bicameral institution in a polarized environment, and the often-overlooked policy outputs of the institution.
This book brings together leading scholars of Congress to provide a general overview of the entire field. Each chapter covers the cutting-edge developments on its respective topic. As the political institution responsible for enacting laws, the American public regularly looks to the U.S. Congress to address the important issues of the day. The contributors in this volume help explain why staying atop the research trends helps us better understand these issues in the ever-changing field of American politics.
New to the Second Edition
New and updated chapters highlighting party recruitment, redistricting, women in Congress, the nationalization of Congressional elections, and the reassertion of Congressional oversight.
A first look at Congressional-executive relations in the Trump era.
Updated data through the 2018 Midterm elections.
eBook
The Substance of Representation
Lawmaking is crucial to American democracy because it completely defines and regulates the public life of the nation. Yet despite its importance, political scientists spend very little time studying the direct impact that the politics surrounding a particular issue has on lawmaking. The Substance of Representation draws on a vast range of historical and empirical data to better understand how lawmaking works across different policy areas. Specifically, John Lapinski introduces a theoretically grounded method for parsing policy issues into categories, and he shows how policymaking varies in predictable ways based on the specific issue area being addressed.
Lapinski examines the ways in which key factors that influence policymaking matter for certain types of policy issues, and he includes an exhaustive look at how elite political polarization shifts across these areas. He considers how Congress behaves according to the policy issue at hand, and how particular areas--such as war, sovereignty issues, and immigration reform--change legislative performance. Relying on records of all Congressional votes since Reconstruction and analyzing voting patterns across policy areas from the late nineteenth to late twentieth centuries, Lapinski provides a comprehensive historical perspective on lawmaking in order to shed light on current practices.
Giving a clear picture of Congressional behavior in the policymaking process over time, The Substance of Representation provides insights into the critical role of American lawmaking.
eBook
Improving Health Research on Small Populations
The increasing diversity of population of the United States presents many challenges to conducting health research that is representative and informative. Dispersion and accessibility issues can increase logistical costs; populations for which it is difficult to obtain adequate sample size are also likely to be expensive to study. Hence, even if it is technically feasible to study a small population, it may not be easy to obtain the funding to do so. In order to address the issues associated with improving health research of small populations, the National Academies of Sciences, Engineering, and Medicine convened a workshop in January 2018. Participants considered ways of addressing the challenges of conducting epidemiological studies or intervention research with small population groups, including alternative study designs, innovative methodologies for data collection, and innovative statistical techniques for analysis.
eBook
Developing an Effective Professional Panel
Plenary panel planning and implementation, carried out by temporary teams, are described for nursing organizations and professional development across settings. The conference or meeting theme and objectives frame panel member selection and moderator focus. Panelist conversations highlight different career trajectories and connect with attendees. [ J Contin Educ Nurs . 2020;51(3):100–102.]
Journal Article
Blood and Blood Products
This volume explores the safety and availability of the nation's supply of blood and blood components. It discusses the risks of disease transmission, methods of guarding the blood supply, new ideas on safety and monitoring, risk tolerance, risk communication, and no-fault insurance.
eBook
The First Rotavirus Vaccine and the Politics of Acceptable Risk
Context: Vaccination in the United States is a frequent source of controversy, with critics alleging failures by public health officials to adequately identify, monitor, and respond to risks associated with vaccines. In response to these charges, the case of RotaShield, a vaccine withdrawn in 1999 following confirmation of a serious adverse event associated with its use, is regularly invoked as evidence of the effectiveness of current vaccine safety activities. Methods: This article examines the history of RotaShield, with particular attention paid to decision making regarding its use in the United States and internationally. I reviewed and analyzed federal advisory committee meeting transcripts, international conference reports, government and scientific publications, media coverage, and other primary and secondary source materials. I also conducted six semistructured interviews with former senior officials and advisory committee members at the U.S. Centers for Disease Control and Prevention who participated in decisions regarding the vaccine. Findings: Decision making regarding RotaShield, including the ultimate withdrawal of its recommendation for use, was shaped significantly by government health officials' concern for preserving public confidence in overall U.S. vaccination efforts amid several unrelated vaccine risk controversies ongoing at that time. This attention to public perception and external pressures occurred in tandem with the evaluation of the quantitative evidence regarding the magnitude and severity of the risk associated with the vaccine. The decisions made in the United States resulted in foreseen but unintended consequences for international use of the vaccine, including in nations where the profile of risks and potential benefits was dramatically different. Conclusions: As enthusiasm for evidence-based decision making grows throughout medicine and public health, greater explicit attention should be directed to the processes by which decision makers and their expert advisers evaluate such evidence and translate it into regulation and policy by means of qualitative judgments.
Journal Article
Contemporary Issues for Protecting Patients in Cancer Research
In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially. These studies have become more complex, with multisite trials now common, and there is increasing use of archived biospecimens and related data, including genomics data. In addition, growing emphasis on targeted cancer therapies requires greater collaboration and sharing of research data to ensure that rare patient subsets are adequately represented. Electronic records enable more extensive data collection and mining, but also raise concerns about the potential for inappropriate or unauthorized use of data, bringing patient protections into a new landscape. There are also long-standing concerns about the processes and forms used to obtain informed consent from patients participating in clinical studies. These changes and challenges raise new ethical and practical questions for the oversight of clinical studies, and for protecting patients and their health information in an efficient manner that does not compromise the progress of biomedical research.
Contemporary Issues for Protecting Patients in Cancer Research is the summary of a workshop convened by the National Cancer Policy Forum of the Institute of Medicine in February 2014 to explore contemporary issues in human subjects protections as they pertain to cancer research, with the goal of identifying potential relevant policy actions. Clinical researchers, government officials, members of Institutional Review Boards, and patient advocates met to discuss clinical cancer research and oversight. This report examines current regulatory provisions that may not adequately protect patients or may be hindering research, and discusses potential strategies and actions to address those challenges.
eBook